vs
Embecta Corp.（EMBC）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Embecta Corp.的季度营收约是Ranger Energy Services, Inc.的1.8倍（$261.2M vs $142.2M），Embecta Corp.净利率更高（16.9% vs 2.3%，领先14.6%），Embecta Corp.同比增速更快（-0.3% vs -0.6%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $16.6M），过去两年Ranger Energy Services, Inc.的营收复合增速更高（1.9% vs -4.6%）
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
EMBC vs RNGR — 直观对比
营收规模更大
EMBC
是对方的1.8倍
$142.2M
营收增速更快
EMBC
高出0.4%
-0.6%
净利率更高
EMBC
高出14.6%
2.3%
自由现金流更多
RNGR
多$500.0K
$16.6M
两年增速更快
RNGR
近两年复合增速
-4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $261.2M | $142.2M |
| 净利润 | $44.1M | $3.2M |
| 毛利率 | 61.9% | — |
| 营业利润率 | 31.9% | 2.3% |
| 净利率 | 16.9% | 2.3% |
| 营收同比 | -0.3% | -0.6% |
| 净利润同比 | — | -44.8% |
| 每股收益（稀释后） | $0.74 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EMBCRNGR
| Q4 25 | $261.2M | $142.2M | ||
| Q3 25 | $264.0M | $128.9M | ||
| Q2 25 | $295.5M | $140.6M | ||
| Q1 25 | $259.0M | $135.2M | ||
| Q4 24 | $261.9M | $143.1M | ||
| Q3 24 | $286.1M | $153.0M | ||
| Q2 24 | $272.5M | $138.1M | ||
| Q1 24 | $287.2M | $136.9M |
净利润EMBCRNGR
| Q4 25 | $44.1M | $3.2M | ||
| Q3 25 | $26.4M | $1.2M | ||
| Q2 25 | $45.5M | $7.3M | ||
| Q1 25 | $23.5M | $600.0K | ||
| Q4 24 | $0 | $5.8M | ||
| Q3 24 | $14.6M | $8.7M | ||
| Q2 24 | $14.7M | $4.7M | ||
| Q1 24 | $28.9M | $-800.0K |
毛利率EMBCRNGR
| Q4 25 | 61.9% | — | ||
| Q3 25 | 60.0% | — | ||
| Q2 25 | 66.7% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 60.7% | — | ||
| Q2 24 | 69.8% | — | ||
| Q1 24 | 64.6% | — |
营业利润率EMBCRNGR
| Q4 25 | 31.9% | 2.3% | ||
| Q3 25 | 21.4% | 2.0% | ||
| Q2 25 | 31.8% | 6.1% | ||
| Q1 25 | 24.3% | 0.7% | ||
| Q4 24 | 11.0% | 6.2% | ||
| Q3 24 | 9.2% | 8.4% | ||
| Q2 24 | 20.5% | 5.3% | ||
| Q1 24 | 13.6% | -0.4% |
净利率EMBCRNGR
| Q4 25 | 16.9% | 2.3% | ||
| Q3 25 | 10.0% | 0.9% | ||
| Q2 25 | 15.4% | 5.2% | ||
| Q1 25 | 9.1% | 0.4% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | 5.1% | 5.7% | ||
| Q2 24 | 5.4% | 3.4% | ||
| Q1 24 | 10.1% | -0.6% |
每股收益（稀释后）EMBCRNGR
| Q4 25 | $0.74 | $0.14 | ||
| Q3 25 | $0.44 | $0.05 | ||
| Q2 25 | $0.78 | $0.32 | ||
| Q1 25 | $0.40 | $0.03 | ||
| Q4 24 | $0.00 | $0.24 | ||
| Q3 24 | $0.24 | $0.39 | ||
| Q2 24 | $0.25 | $0.21 | ||
| Q1 24 | $0.50 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $201.3M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-613.1M | $300.1M |
| 总资产 | $1.1B | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EMBCRNGR
| Q4 25 | $201.3M | $10.3M | ||
| Q3 25 | $225.5M | $45.2M | ||
| Q2 25 | $230.6M | $48.9M | ||
| Q1 25 | $209.3M | $40.3M | ||
| Q4 24 | $210.0M | $40.9M | ||
| Q3 24 | $267.5M | $14.8M | ||
| Q2 24 | $275.1M | $8.7M | ||
| Q1 24 | $299.8M | $11.1M |
总债务EMBCRNGR
| Q4 25 | — | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $1.6B | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益EMBCRNGR
| Q4 25 | $-613.1M | $300.1M | ||
| Q3 25 | $-650.6M | $270.0M | ||
| Q2 25 | $-669.6M | $276.9M | ||
| Q1 25 | $-736.2M | $272.6M | ||
| Q4 24 | $-768.8M | $273.8M | ||
| Q3 24 | $-738.3M | $267.6M | ||
| Q2 24 | $-763.7M | $260.5M | ||
| Q1 24 | $-769.6M | $261.7M |
总资产EMBCRNGR
| Q4 25 | $1.1B | $419.3M | ||
| Q3 25 | $1.1B | $372.8M | ||
| Q2 25 | $1.2B | $381.7M | ||
| Q1 25 | $1.1B | $376.5M | ||
| Q4 24 | $1.1B | $381.6M | ||
| Q3 24 | $1.3B | $373.9M | ||
| Q2 24 | $1.3B | $359.6M | ||
| Q1 24 | $1.2B | $355.5M |
负债/权益比EMBCRNGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.2M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $16.6M | $17.1M |
| 自由现金流率自由现金流/营收 | 6.4% | 12.0% |
| 资本支出强度资本支出/营收 | 0.2% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.39× | 7.53× |
| 过去12个月自由现金流最近4个季度 | $205.8M | $42.9M |
8季度趋势，按日历期对齐
经营现金流EMBCRNGR
| Q4 25 | $17.2M | $24.1M | ||
| Q3 25 | $84.0M | $13.6M | ||
| Q2 25 | $81.2M | $20.7M | ||
| Q1 25 | $31.8M | $10.6M | ||
| Q4 24 | $-5.3M | $32.7M | ||
| Q3 24 | $26.6M | $17.7M | ||
| Q2 24 | $-2.1M | $22.1M | ||
| Q1 24 | $24.3M | $12.0M |
自由现金流EMBCRNGR
| Q4 25 | $16.6M | $17.1M | ||
| Q3 25 | $76.7M | $8.0M | ||
| Q2 25 | $80.8M | $14.4M | ||
| Q1 25 | $31.7M | $3.4M | ||
| Q4 24 | $-6.8M | $27.3M | ||
| Q3 24 | — | $10.8M | ||
| Q2 24 | $-11.8M | $6.8M | ||
| Q1 24 | $20.9M | $5.5M |
自由现金流率EMBCRNGR
| Q4 25 | 6.4% | 12.0% | ||
| Q3 25 | 29.1% | 6.2% | ||
| Q2 25 | 27.3% | 10.2% | ||
| Q1 25 | 12.2% | 2.5% | ||
| Q4 24 | -2.6% | 19.1% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | -4.3% | 4.9% | ||
| Q1 24 | 7.3% | 4.0% |
资本支出强度EMBCRNGR
| Q4 25 | 0.2% | 4.9% | ||
| Q3 25 | 2.8% | 4.3% | ||
| Q2 25 | 0.1% | 4.5% | ||
| Q1 25 | 0.0% | 5.3% | ||
| Q4 24 | 0.6% | 3.8% | ||
| Q3 24 | 0.0% | 4.5% | ||
| Q2 24 | 3.6% | 11.1% | ||
| Q1 24 | 1.2% | 4.7% |
现金转化率EMBCRNGR
| Q4 25 | 0.39× | 7.53× | ||
| Q3 25 | 3.18× | 11.33× | ||
| Q2 25 | 1.78× | 2.84× | ||
| Q1 25 | 1.35× | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | 1.82× | 2.03× | ||
| Q2 24 | -0.14× | 4.70× | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
